Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria

New England Journal of Medicine

Volumn 320, Issue 24, 1989, Pages 1586-1591

  Grau, Georges E ^a   Taylor, Terrie E ^b   Molyneux, Malcolm E ^c   Wirima, Jack J ^d   Vassalli, Pierre ^a   Hommel, Marcel ^c   Lambert, Paul Henri ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d KAMUZU CENTRAL HOSPITAL   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

CHILD; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOON;

EID: 0024327071     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198906153202404     Document Type: Article

References (46)

1. Noguer A, Wernsdorfer W, Kouznetsov R, Hempel J. The malaria situation in 1976. WHO Chron 1978; 32.: 9-17.
2. Greenwood BM, Bradley AK, Greenwood AM, et al. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 1987; 81.: 478-86.
3. White NJ. Pathophysiology. Clin Trop Med Commun Dis 1986; 1.: 85-90.
4. Phillips RE, Warrell DA. The pathophysiology of severe falciparum malaria. Parasitol Today 1986; 2.: 271-82.
5. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72.: 3666-70.
6. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987; 165.: 1581-94.
7. Scuderi P, Sterling KE, Lam KS, et al. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 1986; 2.: 1364-5.
8. van der Meer JW, Endres S, Lonnemann G, et al. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukocyte Biol 1988; 43.: 216-23.
9. Kwiatkowski D, Manogue K, Cerami A, Greenwood BM. Cachectin (tumor necrosis factor) levels in children with falciparum malaria. In.: Kager PA, Polderman AM, Goudsmit J, Laarman JJ, Vogel LC, eds. 12th International Congress for Tropical Medicine and Malaria, 18-23 September 1988, Amsterdam, the Netherlands.: abstracts. Amsterdam.: Excerpta Medica, 1988.:250.
10. Kern P, Hemmer C, Horstmann RD, Dietrich M. Raised serum levels of tumor necrosis factor in severe malaria infection. In.: Kager PA, Polderman AM, Goudsmit J, Laarman JJ, Vogel LC, eds. 12th International Congress for Tropical Medicine and Malaria, 18-23 September 1988, Amsterdam, the Netherlands.: abstracts. Amsterdam.: Excerpta Medica, 1988.:24.
11. Grau GE, Fajardo LF, Piguet P-F, Allet B, Lambert P-H, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987; 237.: 1210-2.
12. Clark IA, Virelizier JL, Carswell EA, Wood PR. Possible importance of macrophage-derived mediators in acute malaria. Infect Immun 1981; 32.: 1058-66.
13. Tubbs H. Endotoxin in human and murine malaria. Trans R Soc Trop Med Hyg 1980; 74.: 121-3.
14. Usawattanakul W, Tharavanij S, Warrell DA, et al. Factors contributing to cerebral malaria. II. Endotoxin. Clin Exp Immunol 1985; 61.: 562-8.
15. Beutler BA, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis.: mechanisms of endotoxin resistance. Science 1986; 232.: 977-80.
16. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234.: 470-4.
17. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318.: 1481-6.
18. Teasdale G, Jennett B. Assessment of coma and impaired consciousness.: a practical scale. Lancet 1974; 2.: 81-4.
19. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in pediatric cerebral malaria.: a study of 131 comatose Malawian children. Q J Med 1989; 71.: 441-59.
20. Field JW. A simple and rapid method of staining malarial parasites in thick blood smears. Trans R Soc Trop Med Hyg 1940; 34.: 195-202.
21. James SP. A note on the Shute technique for staining malaria parasites with Leishman's stain and on the stippling in infected red blood corpuscles which it reveals. Trans R Soc Trop Med Hyg 1929; 23.: 269-78.
22. Ruff MR, Gifford GE. Purification and physico-chemical characterization of rabbit tumor necrosis factor. J Immunol 1980; 125.: 1671-7.
23. Girardin E, Grau GE, Dayer J-M, Roux-Lombard P, J5 Study Group, Lambert P-H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988; 319.: 397-400.
24. Leist TP, Frei K, Kam-Hansen S, Zinkernagel RM, Fontana A. Tumor necrosis factor alpha in the cerebrospinal fluid during bacterial, but not viral, meningitis.: evaluation in murine model infections and in patients. J Exp Med 1988; 167.: 1743-8.
25. Warrell DA, Looareesuwan S, Phillips RE, et al. Function of the blood-cerebrospinal fluid barrier in human cerebral malaria.: rejection of the permeability hypothesis. Am J Trop Med Hyg 1986; 35.: 882-9.
26. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1.: 355-7.
27. Old LJ. Tumor necrosis factor.: another chapter in the long history of endotoxin. Nature 1987; 330.: 602-3.
28. Aung-Kyaw-Zaw, Khin-Maung-U, Myo-Thwe. Endotoxaemia in complicated falciparum malaria. Trans R Soc Trop Med Hyg 1988; 82.: 513-4.
29. Hotez PJ, Le Trang N, Fairlamb AH, Cerami A. Lipoprotein lipase suppression in 3T3-L1 cells by a haemoprotozoan-induced mediator from peritoneal exudate cells. Parasite Immunol 1984; 6.: 203-9.
30. Taverne J, Treagust JD, Playfair JH. Macrophage cytotoxicity in lethal and nonlethal murine malaria and the effect of vaccination. Clin Exp Immunol 1986; 66.: 44-51.
31. Kettelhut IC, Fiers W, Goldberg AL. The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci USA 1987; 84.: 4273-7.
32. Filkins JP, Cornell RP. Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock. Am J Physiol 1974; 227.: 778-81.
33. White NJ, Miller KD, Marsh K, et al. Hypoglycaemia in African children with severe malaria. Lancet 1987; 1.: 708-11.
34. Taylor TE, Molyneux ME, Wirima JJ, Fletcher KA, Morris K. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N Engl J Med 1988; 319.: 1040-7.
35. Mathison JC, Wolfson E, Ulevitch RJ. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988; 81.: 1925-37.
36. Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986; 320.: 584-8.
37. Cerami A, Tracey KJ, Lowry SF, Beutler B. Cachectin.: a pluripotent hormone released during the host response to invasion. Recent Prog Horm Res 1987; 43.: 99-112.
38. Beutler B, Cerami A. Cachectin.: more than a tumor necrosis factor. N Engl J Med 1987; 316.: 379-85.
39. Kwiatkowski D. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. J Exp Med 1989; 169.: 357-61.
40. Duff GW, Durum SK. Fever and immunoregulation.: hyperthermia, interleukins 1 and 2, and T-cell proliferation. Yale J Biol Med 1982; 55.: 437-42.
41. Jampel HD, Duff GW, Gershon RK, Atkins E, Durum SK. Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med 1983; 157.: 1229-38.
42. Haidaris CG, Haynes JD, Meltzer MS, Allison achãƒÂ©al. Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum. Infect Immun 1983; 42.: 385-93.
43. Clark IA, Hunt NH, Butcher GA, Cowden WB. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-γ or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J Immunol 1987; 139.: 3493-6.
44. Grau GE, Piguet PF, Vassalli P, Lambert PH. Involvement of tumor necrosis factor and other cytokines in immune-mediated vascular pathology. Int Arch Allergy Appl Immunol 1989; 88.: 34-9.
45. Warren RS, Starnes HF Jr, Gabrilove JL, Oettgen HF, Brennan MF. The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 1987; 122.: 1396-400.
46. Blick M, Sherwin SA, Rosenblum M, Gutterman J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 1987; 47.: 2986-9.